In anoestrous dairy cows, do GnRH-based vs progesterone-based synchronisation programmes give better pregnancy rates to timed AI?
Shelf #874 · gate-verified and approved by the developer
POSSIBLE: In anoestrous dairy cows, programmes that include a progesterone device give somewhat better pregnancy rates to timed AI than GnRH-based programmes without progesterone, but the advantage is modest in the largest trial and large only in one older trial's anoestrous subgroup. In Shephard 2013 (PMID: 23829605; 1,906 anoestrous cows from 12 New Zealand herds, randomly assigned), conception to fixed-time AI was 0.34 (95% CI 0.29-0.37) with the GnRH-based GPG programme alone (gonadorelin day -10, cloprostenol day -3, gonadorelin day -1) vs 0.38 (95% CI 0.34-0.43) when a 1.38 g progesterone CIDR device was added for days -10 to -3 and 0.38 (95% CI 0.33-0.42) with a 1.0 g DIB progesterone device — absolute differences of about 4 percentage points (relative risk about 1.12) — and pregnancy by day 28 was 0.55 (95% CI 0.51-0.60) for GPG vs 0.57 (95% CI 0.52-0.61) for CIDR and 0.56 (95% CI 0.52-0.60) for DIB, with no difference between the two progesterone devices; adding equine chorionic gonadotrophin to the DIB programme (0.41 conception, 0.63 pregnant by day 28) helped only in cows more than 60 days calved, where it beat GPG (p < 0.001). In Cavestany 2003 (PMID: 12695051; 742 lactating Holstein cows, 27.4% anoestrous by milk progesterone), overall pregnancy rates were similar (20%) between Ovsynch and Ovsynch plus a medroxyprogesterone acetate sponge, but in anoestrous cows specifically pregnancy rate was 34.9% with the progestin added vs 11.1% with Ovsynch alone (treatment-by-cyclicity interaction P < 0.001; absolute difference 23.8 percentage points). Design class (b): randomisation is established by Shephard 2013, which randomly assigned anoestrous cows to the GnRH-based programme with or without a progesterone device and so answers this shelf's own comparison in this shelf's own population; blinding is not established in either carded record (device insertion cannot readily be masked and neither record states masked outcome assessment — pregnancy was diagnosed objectively). The stamp is POSSIBLE, not LIKELY, because the two carded trials point the same way but with very different effect sizes, the larger and more recent trial's device effect is small and its confidence intervals overlap the GnRH-only arm, and the large anoestrous-subgroup effect comes from a mixed cycling/anoestrous trial using a medroxyprogesterone sponge rather than a progesterone device. Tier C is not engaged: the primary claim is a pregnancy-rate benefit, which is not a mortality, fetal-loss or survival claim. One-home cross-points: Ovsynch vs insemination at detected oestrus homes on shelf #359 and the CIDR programme vs no treatment in anoestrous cows homes on shelf #360 (whose McDougall records are not re-carded here); progesterone supplementation after AI in repeat breeders is topic #875 and ewe sponge vs CIDR is topic #913 — different comparisons and populations. A further near-miss, not carded: Ozturk 2010 (PMID: 20022363) randomised 51 anoestrous primiparous cows between two GnRH-based protocols (Doublesynch vs Ovsynch, overall pregnancy 72.8% vs 29.8%) — a comparison within GnRH-based programmes with no progesterone arm, so it cannot carry this shelf's claim. Drafted Nov 10, 2026 (VetMed build, topic #874); figures from the abstracts, fetched and verified at drafting.
Randomised controlled field trial in anoestrous cows (record states cows were randomly assigned; publication types: Journal Article)
Who: Dairy cows: 1,906 anoestrous cows from 12 New Zealand herds, randomly assigned to four treatments built on a gonadotrophin-prostaglandin-gonadotrophin (GPG) programme (100 micrograms gonadorelin day -10; 500 micrograms cloprostenol day -3; 100 micrograms gonadorelin day -1; fixed-time AI day 0): GPG alone (n = 475), GPG plus a CIDR intravaginal device containing 1.38 g progesterone inserted days -10 to -3 (n = 477), GPG plus a DIB device containing 1.0 g progesterone days -10 to -3 (n = 477), or DIB plus 400 IU equine chorionic gonadotrophin at day -3 (n = 477).
Result: Conception to fixed-time AI was 0.34 (95% CI 0.29-0.37) for GPG, 0.38 (95% CI 0.34-0.43) for CIDR, 0.38 (95% CI 0.33-0.42) for DIB and 0.41 (95% CI 0.37-0.46) for DIB + eCG — absolute gains of about 4 percentage points for either progesterone device over GPG alone (relative risk about 1.12). Pregnancy by day 28 was 0.55 (95% CI 0.51-0.60), 0.57 (95% CI 0.52-0.61), 0.56 (95% CI 0.52-0.60) and 0.63 (95% CI 0.59-0.67) respectively. There was an interaction between treatment and days calved (p < 0.05): cows more than 60 days calved treated with DIB + eCG had higher fixed-time AI conception and 28-day pregnancy rates than GPG cows (p < 0.001). Median interval to conception did not differ between treatments, and there were no differences between the DIB and CIDR devices for any parameter (p > 0.05).
Watch out: The progesterone comparison on this card is device-added-to-GPG vs GPG alone — every arm received GnRH, so this tests progesterone inclusion, not a wholly separate progesterone-only programme. The headline device effects are small with overlapping confidence intervals, the record reports no overall significance test isolating the device effect, and the only clearly significant advantage (DIB + eCG in cows >60 days calved) belongs to the eCG addition, not to progesterone itself. Seasonal, pasture-based New Zealand herds; results may not transport to year-round housed herds.
Shephard RW. Efficacy of inclusion of equine chorionic gonadotrophin into a treatment protocol for anoestrous dairy cows. N Z Vet J. 2013;61(6):330-6. PMID: 23829605. Registry ID: none in the record. MeSH: Anestrus/drug effects* · Animals · Cattle/physiology* · Chorionic Gonadotropin/administration & dosage/classification/pharmacology* · Dairying* · Estrus Synchronization/methods · Female · Horses · Insemination, Artificial/veterinary · Pregnancy · Progesterone/administration & dosage/pharmacology
Comparative controlled trial, mixed cycling and anoestrous population with an anoestrous subgroup analysis (publication types: Comparative Study, Evaluation Study, Journal Article)
Who: Dairy cattle: 742 lactating Holstein cows more than 40 days postpartum (Uruguay), of which 27.4% were anoestrous by milk progesterone on days -17 and -10, assigned to Ovsynch (GnRH day 0; prostaglandin F2alpha day 7; GnRH day 9; timed AI 16-20 h later) or the same Ovsynch plus an intravaginal polyurethane sponge impregnated with 300 mg medroxyprogesterone acetate inserted after the first GnRH and removed at the prostaglandin treatment on day 7; resynchronisation arms followed after timed AI.
Result: Pregnancy rates were similar in both pre-breeding treatments (20%), but an interaction (P < 0.001) was detected between treatment and cyclicity: for anoestrous cows, pregnancy rate was 34.9% with the progestin sponge added vs 11.1% with Ovsynch alone (absolute difference 23.8 percentage points; relative rate about 3.1). At the prostaglandin injection, 67.7% of cycling cows but only 21.3% of anoestrous cows had elevated progesterone; on day 20 after timed AI, 42.6% of cycling and 8.3% of anoestrous cows had elevated progesterone. Resynchronisation produced more cows in oestrus between days 18 and 25 after timed AI (P < 0.001), but conception rate in the resynchronisation treatment was lower than in the no-resynchronisation group (22.8% vs 47.4%, P < 0.05). The authors concluded that adding a progestin to Ovsynch increased pregnancy rates in cows treated during anoestrus, while the benefit in cycling cows was equivocal.
Watch out: The anoestrous result is a subgroup of a mixed-population trial — only 27.4% of the 742 cows were anoestrous, and the abstract does not state that allocation was randomised, so this card alone is design class (c); the shelf's class (b) rests on Shephard 2013. The progestin was medroxyprogesterone acetate in a sponge, not a progesterone CIDR/DIB device, and subgroup denominators are not given in the abstract, so the 34.9% vs 11.1% contrast cannot be precision-weighted from the record.
Cavestany D, Cibils J, Freire A, Sastre A, Stevenson JS. Evaluation of two different oestrus-synchronisation methods with timed artificial insemination and resynchronisation of returns to oestrus in lactating Holstein cows. Anim Reprod Sci. 2003;77(3-4):141-55. PMID: 12695051. Registry ID: none in the record. MeSH: Administration, Intravaginal · Animals · Cattle/physiology* · Dinoprost/administration & dosage · Estrus/physiology · Estrus Synchronization/methods* · Female · Fertility · Gonadotropin-Releasing Hormone/administration & dosage/analogs & derivatives · Insemination, Artificial* · Lactation* · Medroxyprogesterone Acetate/administration & dosage · Milk/chemistry · Pregnancy · Progesterone/analysis · Time Factors · Uruguay
Synthesis
Who: Synthesis of the two cards above (Shephard 2013, 1,906 anoestrous cows; Cavestany 2003, 742 cows of whom 27.4% anoestrous) and of the near-miss record documented in the result, fetched at drafting and deliberately not carded as a claim-carrier.
Result: (1) Direction: both carded trials favour including progesterone — conception/pregnancy gains of about 4 percentage points for a device added to GPG in anoestrous cows (Shephard: 0.38 vs 0.34 to fixed-time AI; 0.57/0.56 vs 0.55 pregnant by day 28) and a large anoestrous-subgroup gain when a progestin sponge was added to Ovsynch (Cavestany: 34.9% vs 11.1%). (2) Size and certainty: the larger, anoestrous-only randomised trial shows the smaller effect, so the honest summary is a probable small benefit, with the large subgroup figure likely an overestimate of the device effect in unselected anoestrous cows. (3) Near-miss not carded: Ozturk 2010 (PMID: 20022363) put 165 primiparous Holstein cows (51 anoestrous) randomly into Ovsynch or Doublesynch and found higher pregnancy rates with Doublesynch overall (72.8% vs 29.8%, P < 0.0001) including in anoestrous cows — but both protocols are GnRH-based and neither contains progesterone, so it answers a within-GnRH question, not this shelf's comparison. (4) Design class (b): randomisation is established by Shephard 2013 answering this shelf's own comparison and population; blinding is not established in either carded record. Tier C is not engaged — a pregnancy-rate primary benefit is not Tier C.
Watch out: One-home check at drafting: none of PMIDs 23829605, 12695051 or 20022363 appears in any other pack on disk; shelf #360's McDougall records (PMIDs: 20412908, 16032310) compare a combined GnRH/prostaglandin/progesterone treatment against no treatment and are cross-pointed, not re-carded. Do not quote the 34.9% vs 11.1% subgroup contrast without the Shephard trial's much smaller device effect beside it, and do not transport the eCG finding (a third drug, in cows >60 days calved) into a claim about progesterone.
Synthesis of Shephard RW. PMID: 23829605; Cavestany D et al. PMID: 12695051; Ozturk OA et al. PMID: 20022363. Registry IDs as on the individual cards (none in the records).
Back to the library index · VetMed home
VetMed is an educational resource, not veterinary advice.